ReviewPharmaceuticals (Basel, Switzerland)2022

Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Sergio Marin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.